GKOS: Glaukos Corporation

98.46 USD 0.98 (0.99%)

Settore: Salute Base: US Dollar Valuta di profitto: US Dollar

Il tasso di cambio GKOS ha avuto una variazione del -0.99% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 97.52 e ad un massimo di 100.19.

Segui le dinamiche di Glaukos Corporation. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.

Grafico a schermo intero

GKOS News

Investing 12:31 Stifel reiterates Buy rating on Glaukos stock, cites positive iDose feedback
Investing 20:17 Glaukos receives EU certification for glaucoma surgery devices
Investing 11:24 Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell
Seeking Alpha 14:07 Glaukos Corporation: Delivering Consistent Growth (NYSE:GKOS)
Investing 13:14 Piper Sandler names Abbott, Edwards, Glaukos as top medtech catalyst picks
Seeking Alpha 04:30 Thornburg Small/Mid Cap Growth Fund Q1 2025 Commentary
Seeking Alpha 15:09 Harbor Health Care ETF Q1 2025 Commentary (undefined:MEDI)
Investing 13:44 Stifel maintains buy rating on Glaukos stock, $115 target unchanged
Investing 20:56 glaukos corp reports annual meeting voting results
Seeking Alpha 12:54 Lord Abbett Growth Leaders Fund Q1 2025 Commentary (Mutual Fund:LGLAX)
Investing 18:01 Glaukos at Stifel Forum: iDose Launch and Strategic Outlook
Seeking Alpha 16:25 Columbia Acorn Fund Q1 2025 Commentary (Mutual Fund:ACRNX)
Benzinga 17:40 This Parsons Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday - Glaukos (NYSE:GKOS), Parsons (NYSE:PSN)
Seeking Alpha 12:00 ClearBridge Small Cap Growth Strategy Q1 2025 Commentary (Mutual Fund:LMOIX)
Seeking Alpha 12:48 Glaukos: Macro Environment & Limited Market Access Could Stunt Growth Plans (NYSE:GKOS)
Seeking Alpha 04:01 Lord Abbett Developing Growth Fund Q4 2024 Commentary
Seeking Alpha 19:59 Baird Q4 2024 Small/Mid Cap Growth Equity Commentary
Seeking Alpha 15:10 Columbia Acorn Fund Q4 2024 Commentary (ACRNX)
Seeking Alpha 14:00 Invesco Small Cap Growth Fund Q4 2024 Commentary
Seeking Alpha 07:17 Fidelity Small Cap Growth Fund Q4 2024 Review (Mutual Fund:FCPGX)
Benzinga 14:12 FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery - Glaukos (NYSE:GKOS)
Benzinga 18:01 Consumer Sentiment Drops 10%, UnitedHealth Under Investigation: What's Driving Markets Friday? - SPDR S&P 500 (ARCA:SPY)
Benzinga 15:27 Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition - Glaukos (NYSE:GKOS)
Seeking Alpha 09:29 Glaukos Corporation (GKOS) Q4 2024 Earnings Call Transcript

Intervallo Giornaliero

97.52 100.19

Intervallo Annuale

77.11 163.71

Chiusura Precedente: 98.31
Apertura: 99.44

Bid: 98.46
Ask: 98.76

Minimo: 97.52
Massimo: 100.19

Volume: 2.217 K

Variazione giornaliera: -0.99%
Variazione Mensile: -3.57%

Variazione Semestrale: -36.47%
Variazione Annuale: -10.08%

16 luglio, mercoledì